Show simple item record

dc.contributor.authorPirani, Tasneem
dc.contributor.authorWilson, Anthony
dc.contributor.authorBrealey, David
dc.contributor.authorLow, Ryan
dc.contributor.authorO'Neill, Suzanne
dc.contributor.authorLe, Jenny
dc.contributor.authorJhanji, Shaman
dc.contributor.authorBangash, Mansoor N
dc.contributor.authorMathew, Amrith
dc.contributor.authorWright, Christopher
dc.contributor.authorLatif, Anne-Louise
dc.contributor.authorIrvine, David
dc.contributor.authorKasipandian, Vidya
dc.contributor.authorSingh, Neeraj
dc.contributor.authorSaha, Rohit
dc.contributor.authorMetaxa, Victoria
dc.date.accessioned2024-04-09T14:04:52Z
dc.date.available2024-04-09T14:04:52Z
dc.date.issued2024-03-22
dc.identifier.citationPirani T, Wilson A, Brealey D, Low R, O'Neill S, Le J, Jhanji S, Bangash MN, Mathew A, Wright C, Latif AL, Irvine D, Kasipandian V, Singh N, Saha R, Metaxa V. Critical care utilisation for patients receiving chimeric antigen receptor (CAR) T cell therapy in the UK. Br J Anaesth. 2024 May;132(5):1004-1006. doi: 10.1016/j.bja.2024.01.047. Epub 2024 Mar 22.en_US
dc.identifier.eissn1471-6771
dc.identifier.doi10.1016/j.bja.2024.01.047
dc.identifier.pmid38521658
dc.identifier.urihttp://hdl.handle.net/20.500.14200/4138
dc.description.abstractCritical care utilisation for patients receiving chimeric antigen receptor (CAR) T cell therapy in the UKen_US
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.subjectHaematologyen_US
dc.subjectOncology. Pathology.en_US
dc.titleCritical care utilisation for patients receiving chimeric antigen receptor (CAR) T cell therapy in the UK.en_US
dc.typeArticle
dc.source.journaltitleBritish Journal of Anaesthesia
dc.source.countryEngland
rioxxterms.versionNAen_US
dc.contributor.trustauthorMathew, Amrith
dc.contributor.departmentAR-T Cell Therapy & BMT Fellowen_US
dc.contributor.roleMedical and Dentalen_US
oa.grant.openaccessnaen_US


Files in this item

Thumbnail
Name:
Publisher version

This item appears in the following Collection(s)

Show simple item record